Class Action Lawsuit Filed Against Capricor Therapeutics for Securities Fraud
News related to:Capricor Therapeutics, Inc · 1 min read
LOS ANGELES, Sept. 8, 2026 /CourierPR/ -- Schall, Brown & Schwartz LLP, a national shareholder rights litigation firm, has announced a class action lawsuit against Capricor Therapeutics, Inc., for alleged securities fraud. The lawsuit, which is based on violations of the Securities Exchange Act of 1934, is related to the company's misleading statements to the market during a specific period.
According to the complaint, Capricor Therapeutics, Inc., faced significant risks due to changes in the statistical analysis plan used to analyze the clinical data related to Deramiocel. These changes were made without the FDA’s approval, despite the pre-specified plan. The company’s public statements, which were made during the class period from December 17, 2025, to July 26, 2026, were found to be false and materially misleading. When the market learned the truth, investors suffered substantial losses.
SBS Law is inviting shareholders who purchased shares of CAPR during the class period to contact the firm regarding the possibility of being appointed as lead plaintiff. This role is not required to participate in any recovery, but those interested are encouraged to do so. The deadline for those who wish to participate is September 28, 2026.
The allegations against Capricor Therapeutics, Inc., stem from the company’s failure to disclose the risks associated with the changes in the analysis plan to the FDA. Investors are urged to review their records and consider the firm’s services to protect their interests.
SBS Law, known for its expertise in securities class action lawsuits and shareholder rights litigation, specializes in representing investors around the world. With the extensive experience of its founding partners, Brian Schall, Andrew Brown, and David Schwartz, the firm aims to advocate aggressively for every investor.
Should you have any questions or need further information, you can reach out to SBS Law at 310-301-3335 or through their website at www.schallfirm.com.